T.P.1.01 Use of the 6
min walk test as an endpoint in clinical trials for neuromuscular diseases
No abstract is available. To read the body of this article, please view the Full Text online.
To access this article, please choose from the options below
PII: S0960-8966(08)00215-0
doi:10.1016/j.nmd.2008.06.053
© 2008 Published by Elsevier Inc.
